Chiasma is a biotechnology company devoted to developing non-invasive alternatives to the growing list of high-value macromolecule therapies, all of which currently require administration by injection.
Chiasma Inc.
P.O. Box 395
Georgetown, MA 01833
USA
Tel: 617-378-7474
Fax: 781-207-2432
